2018-2023 Global Immuno-oncology Therapy Consumption Market Report

October 2018 | 164 pages | ID: 23D928FB32CEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Immuno-oncology Therapy market for 2018-2023.
Cancer immunotherapy (sometimes called immuno-oncology) is the use of the immune system to treat cancer.

Over the next five years, LPI(LP Information) projects that Immuno-oncology Therapy will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Immuno-oncology Therapy market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

• Monoclonal Antibodies
• Immune Checkpoint Inhibitors
• Immune System Modulators
• Cancer Vaccines
• Others

Segmentation by application:

• Hospitals
• Ambulatory Surgical Center
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

• Amgen
• AstraZeneca
• Bristol-Myers Squibb
• Eli-Lilly
• Roche
• GlaxoSmithKline
• Janssen Biotech
• Merck
• Novartis
• Pfizer
• Sanofi
• Spectrum Pharmaceuticals
• Takeda

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

RESEARCH OBJECTIVES

• To study and analyze the global Immuno-oncology Therapy consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Immuno-oncology Therapy market by identifying its various subsegments.
• Focuses on the key global Immuno-oncology Therapy manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Immuno-oncology Therapy with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Immuno-oncology Therapy submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

2018-2023 GLOBAL IMMUNO-ONCOLOGY THERAPY CONSUMPTION MARKET REPORT

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Immuno-oncology Therapy Consumption 2013-2023
  2.1.2 Immuno-oncology Therapy Consumption CAGR by Region
2.2 Immuno-oncology Therapy Segment by Type
  2.2.1 Monoclonal Antibodies
  2.2.2 Immune Checkpoint Inhibitors
  2.2.3 Immune System Modulators
  2.2.4 Cancer Vaccines
  2.2.5 Others
2.3 Immuno-oncology Therapy Consumption by Type
  2.3.1 Global Immuno-oncology Therapy Consumption Market Share by Type (2013-2018)
  2.3.2 Global Immuno-oncology Therapy Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Immuno-oncology Therapy Sale Price by Type (2013-2018)
2.4 Immuno-oncology Therapy Segment by Application
  2.4.1 Hospitals
  2.4.2 Ambulatory Surgical Center
  2.4.3 Others
2.5 Immuno-oncology Therapy Consumption by Application
  2.5.1 Global Immuno-oncology Therapy Consumption Market Share by Application (2013-2018)
  2.5.2 Global Immuno-oncology Therapy Value and Market Share by Application (2013-2018)
  2.5.3 Global Immuno-oncology Therapy Sale Price by Application (2013-2018)

3 GLOBAL IMMUNO-ONCOLOGY THERAPY BY PLAYERS

3.1 Global Immuno-oncology Therapy Sales Market Share by Players
  3.1.1 Global Immuno-oncology Therapy Sales by Players (2016-2018)
  3.1.2 Global Immuno-oncology Therapy Sales Market Share by Players (2016-2018)
3.2 Global Immuno-oncology Therapy Revenue Market Share by Players
  3.2.1 Global Immuno-oncology Therapy Revenue by Players (2016-2018)
  3.2.2 Global Immuno-oncology Therapy Revenue Market Share by Players (2016-2018)
3.3 Global Immuno-oncology Therapy Sale Price by Players
3.4 Global Immuno-oncology Therapy Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Immuno-oncology Therapy Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Immuno-oncology Therapy Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 IMMUNO-ONCOLOGY THERAPY BY REGIONS

4.1 Immuno-oncology Therapy by Regions
  4.1.1 Global Immuno-oncology Therapy Consumption by Regions
  4.1.2 Global Immuno-oncology Therapy Value by Regions
4.2 Americas Immuno-oncology Therapy Consumption Growth
4.3 APAC Immuno-oncology Therapy Consumption Growth
4.4 Europe Immuno-oncology Therapy Consumption Growth
4.5 Middle East & Africa Immuno-oncology Therapy Consumption Growth

5 AMERICAS

5.1 Americas Immuno-oncology Therapy Consumption by Countries
  5.1.1 Americas Immuno-oncology Therapy Consumption by Countries (2013-2018)
  5.1.2 Americas Immuno-oncology Therapy Value by Countries (2013-2018)
5.2 Americas Immuno-oncology Therapy Consumption by Type
5.3 Americas Immuno-oncology Therapy Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Immuno-oncology Therapy Consumption by Countries
  6.1.1 APAC Immuno-oncology Therapy Consumption by Countries (2013-2018)
  6.1.2 APAC Immuno-oncology Therapy Value by Countries (2013-2018)
6.2 APAC Immuno-oncology Therapy Consumption by Type
6.3 APAC Immuno-oncology Therapy Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Immuno-oncology Therapy by Countries
  7.1.1 Europe Immuno-oncology Therapy Consumption by Countries (2013-2018)
  7.1.2 Europe Immuno-oncology Therapy Value by Countries (2013-2018)
7.2 Europe Immuno-oncology Therapy Consumption by Type
7.3 Europe Immuno-oncology Therapy Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Immuno-oncology Therapy by Countries
  8.1.1 Middle East & Africa Immuno-oncology Therapy Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Immuno-oncology Therapy Value by Countries (2013-2018)
8.2 Middle East & Africa Immuno-oncology Therapy Consumption by Type
8.3 Middle East & Africa Immuno-oncology Therapy Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Immuno-oncology Therapy Distributors
10.3 Immuno-oncology Therapy Customer

11 GLOBAL IMMUNO-ONCOLOGY THERAPY MARKET FORECAST

11.1 Global Immuno-oncology Therapy Consumption Forecast (2018-2023)
11.2 Global Immuno-oncology Therapy Forecast by Regions
  11.2.1 Global Immuno-oncology Therapy Forecast by Regions (2018-2023)
  11.2.2 Global Immuno-oncology Therapy Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Immuno-oncology Therapy Forecast by Type
11.8 Global Immuno-oncology Therapy Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 Amgen
  12.1.1 Company Details
  12.1.2 Immuno-oncology Therapy Product Offered
  12.1.3 Amgen Immuno-oncology Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 Amgen News
12.2 AstraZeneca
  12.2.1 Company Details
  12.2.2 Immuno-oncology Therapy Product Offered
  12.2.3 AstraZeneca Immuno-oncology Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 AstraZeneca News
12.3 Bristol-Myers Squibb
  12.3.1 Company Details
  12.3.2 Immuno-oncology Therapy Product Offered
  12.3.3 Bristol-Myers Squibb Immuno-oncology Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 Bristol-Myers Squibb News
12.4 Eli-Lilly
  12.4.1 Company Details
  12.4.2 Immuno-oncology Therapy Product Offered
  12.4.3 Eli-Lilly Immuno-oncology Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 Eli-Lilly News
12.5 Roche
  12.5.1 Company Details
  12.5.2 Immuno-oncology Therapy Product Offered
  12.5.3 Roche Immuno-oncology Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 Roche News
12.6 GlaxoSmithKline
  12.6.1 Company Details
  12.6.2 Immuno-oncology Therapy Product Offered
  12.6.3 GlaxoSmithKline Immuno-oncology Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
  12.6.4 Main Business Overview
  12.6.5 GlaxoSmithKline News
12.7 Janssen Biotech
  12.7.1 Company Details
  12.7.2 Immuno-oncology Therapy Product Offered
  12.7.3 Janssen Biotech Immuno-oncology Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
  12.7.4 Main Business Overview
  12.7.5 Janssen Biotech News
12.8 Merck
  12.8.1 Company Details
  12.8.2 Immuno-oncology Therapy Product Offered
  12.8.3 Merck Immuno-oncology Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
  12.8.4 Main Business Overview
  12.8.5 Merck News
12.9 Novartis
  12.9.1 Company Details
  12.9.2 Immuno-oncology Therapy Product Offered
  12.9.3 Novartis Immuno-oncology Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
  12.9.4 Main Business Overview
  12.9.5 Novartis News
12.10 Pfizer
  12.10.1 Company Details
  12.10.2 Immuno-oncology Therapy Product Offered
  12.10.3 Pfizer Immuno-oncology Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
  12.10.4 Main Business Overview
  12.10.5 Pfizer News
12.11 Sanofi
12.12 Spectrum Pharmaceuticals
12.13 Takeda

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Immuno-oncology Therapy
Table Product Specifications of Immuno-oncology Therapy
Figure Immuno-oncology Therapy Report Years Considered
Figure Market Research Methodology
Figure Global Immuno-oncology Therapy Consumption Growth Rate 2013-2023 (K Units)
Figure Global Immuno-oncology Therapy Value Growth Rate 2013-2023 ($ Millions)
Table Immuno-oncology Therapy Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Monoclonal Antibodies
Table Major Players of Monoclonal Antibodies
Figure Product Picture of Immune Checkpoint Inhibitors
Table Major Players of Immune Checkpoint Inhibitors
Figure Product Picture of Immune System Modulators
Table Major Players of Immune System Modulators
Figure Product Picture of Cancer Vaccines
Table Major Players of Cancer Vaccines
Figure Product Picture of Others
Table Major Players of Others
Table Global Consumption Sales by Type (2013-2018)
Table Global Immuno-oncology Therapy Consumption Market Share by Type (2013-2018)
Figure Global Immuno-oncology Therapy Consumption Market Share by Type (2013-2018)
Table Global Immuno-oncology Therapy Revenue by Type (2013-2018) ($ million)
Table Global Immuno-oncology Therapy Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Immuno-oncology Therapy Value Market Share by Type (2013-2018)
Table Global Immuno-oncology Therapy Sale Price by Type (2013-2018)
Figure Immuno-oncology Therapy Consumed in Hospitals
Figure Global Immuno-oncology Therapy Market: Hospitals (2013-2018) (K Units)
Figure Global Immuno-oncology Therapy Market: Hospitals (2013-2018) ($ Millions)
Figure Global Hospitals YoY Growth ($ Millions)
Figure Immuno-oncology Therapy Consumed in Ambulatory Surgical Center
Figure Global Immuno-oncology Therapy Market: Ambulatory Surgical Center (2013-2018) (K Units)
Figure Global Immuno-oncology Therapy Market: Ambulatory Surgical Center (2013-2018) ($ Millions)
Figure Global Ambulatory Surgical Center YoY Growth ($ Millions)
Figure Immuno-oncology Therapy Consumed in Others
Figure Global Immuno-oncology Therapy Market: Others (2013-2018) (K Units)
Figure Global Immuno-oncology Therapy Market: Others (2013-2018) ($ Millions)
Figure Global Others YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Immuno-oncology Therapy Consumption Market Share by Application (2013-2018)
Figure Global Immuno-oncology Therapy Consumption Market Share by Application (2013-2018)
Table Global Immuno-oncology Therapy Value by Application (2013-2018)
Table Global Immuno-oncology Therapy Value Market Share by Application (2013-2018)
Figure Global Immuno-oncology Therapy Value Market Share by Application (2013-2018)
Table Global Immuno-oncology Therapy Sale Price by Application (2013-2018)
Table Global Immuno-oncology Therapy Sales by Players (2016-2018) (K Units)
Table Global Immuno-oncology Therapy Sales Market Share by Players (2016-2018)
Figure Global Immuno-oncology Therapy Sales Market Share by Players in 2016
Figure Global Immuno-oncology Therapy Sales Market Share by Players in 2017
Table Global Immuno-oncology Therapy Revenue by Players (2016-2018) ($ Millions)
Table Global Immuno-oncology Therapy Revenue Market Share by Players (2016-2018)
Figure Global Immuno-oncology Therapy Revenue Market Share by Players in 2016
Figure Global Immuno-oncology Therapy Revenue Market Share by Players in 2017
Table Global Immuno-oncology Therapy Sale Price by Players (2016-2018)
Figure Global Immuno-oncology Therapy Sale Price by Players in 2017
Table Global Immuno-oncology Therapy Manufacturing Base Distribution and Sales Area by Players
Table Players Immuno-oncology Therapy Products Offered
Table Immuno-oncology Therapy Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Immuno-oncology Therapy Consumption by Regions 2013-2018 (K Units)
Table Global Immuno-oncology Therapy Consumption Market Share by Regions 2013-2018
Figure Global Immuno-oncology Therapy Consumption Market Share by Regions 2013-2018
Table Global Immuno-oncology Therapy Value by Regions 2013-2018 ($ Millions)
Table Global Immuno-oncology Therapy Value Market Share by Regions 2013-2018
Figure Global Immuno-oncology Therapy Value Market Share by Regions 2013-2018
Figure Americas Immuno-oncology Therapy Consumption 2013-2018 (K Units)
Figure Americas Immuno-oncology Therapy Value 2013-2018 ($ Millions)
Figure APAC Immuno-oncology Therapy Consumption 2013-2018 (K Units)
Figure APAC Immuno-oncology Therapy Value 2013-2018 ($ Millions)
Figure Europe Immuno-oncology Therapy Consumption 2013-2018 (K Units)
Figure Europe Immuno-oncology Therapy Value 2013-2018 ($ Millions)
Figure Middle East & Africa Immuno-oncology Therapy Consumption 2013-2018 (K Units)
Figure Middle East & Africa Immuno-oncology Therapy Value 2013-2018 ($ Millions)
Table Americas Immuno-oncology Therapy Consumption by Countries (2013-2018) (K Units)
Table Americas Immuno-oncology Therapy Consumption Market Share by Countries (2013-2018)
Figure Americas Immuno-oncology Therapy Consumption Market Share by Countries in 2017
Table Americas Immuno-oncology Therapy Value by Countries (2013-2018) ($ Millions)
Table Americas Immuno-oncology Therapy Value Market Share by Countries (2013-2018)
Figure Americas Immuno-oncology Therapy Value Market Share by Countries in 2017
Table Americas Immuno-oncology Therapy Consumption by Type (2013-2018) (K Units)
Table Americas Immuno-oncology Therapy Consumption Market Share by Type (2013-2018)
Figure Americas Immuno-oncology Therapy Consumption Market Share by Type in 2017
Table Americas Immuno-oncology Therapy Consumption by Application (2013-2018) (K Units)
Table Americas Immuno-oncology Therapy Consumption Market Share by Application (2013-2018)
Figure Americas Immuno-oncology Therapy Consumption Market Share by Application in 2017
Figure United States Immuno-oncology Therapy Consumption Growth 2013-2018 (K Units)
Figure United States Immuno-oncology Therapy Value Growth 2013-2018 ($ Millions)
Figure Canada Immuno-oncology Therapy Consumption Growth 2013-2018 (K Units)
Figure Canada Immuno-oncology Therapy Value Growth 2013-2018 ($ Millions)
Figure Mexico Immuno-oncology Therapy Consumption Growth 2013-2018 (K Units)
Figure Mexico Immuno-oncology Therapy Value Growth 2013-2018 ($ Millions)
Table APAC Immuno-oncology Therapy Consumption by Countries (2013-2018) (K Units)
Table APAC Immuno-oncology Therapy Consumption Market Share by Countries (2013-2018)
Figure APAC Immuno-oncology Therapy Consumption Market Share by Countries in 2017
Table APAC Immuno-oncology Therapy Value by Countries (2013-2018) ($ Millions)
Table APAC Immuno-oncology Therapy Value Market Share by Countries (2013-2018)
Figure APAC Immuno-oncology Therapy Value Market Share by Countries in 2017
Table APAC Immuno-oncology Therapy Consumption by Type (2013-2018) (K Units)
Table APAC Immuno-oncology Therapy Consumption Market Share by Type (2013-2018)
Figure APAC Immuno-oncology Therapy Consumption Market Share by Type in 2017
Table APAC Immuno-oncology Therapy Consumption by Application (2013-2018) (K Units)
Table APAC Immuno-oncology Therapy Consumption Market Share by Application (2013-2018)
Figure APAC Immuno-oncology Therapy Consumption Market Share by Application in 2017
Figure China Immuno-oncology Therapy Consumption Growth 2013-2018 (K Units)
Figure China Immuno-oncology Therapy Value Growth 2013-2018 ($ Millions)
Figure Japan Immuno-oncology Therapy Consumption Growth 2013-2018 (K Units)
Figure Japan Immuno-oncology Therapy Value Growth 2013-2018 ($ Millions)
Figure Korea Immuno-oncology Therapy Consumption Growth 2013-2018 (K Units)
Figure Korea Immuno-oncology Therapy Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Immuno-oncology Therapy Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia Immuno-oncology Therapy Value Growth 2013-2018 ($ Millions)
Figure India Immuno-oncology Therapy Consumption Growth 2013-2018 (K Units)
Figure India Immuno-oncology Therapy Value Growth 2013-2018 ($ Millions)
Figure Australia Immuno-oncology Therapy Consumption Growth 2013-2018 (K Units)
Figure Australia Immuno-oncology Therapy Value Growth 2013-2018 ($ Millions)
Table Europe Immuno-oncology Therapy Consumption by Countries (2013-2018) (K Units)
Table Europe Immuno-oncology Therapy Consumption Market Share by Countries (2013-2018)
Figure Europe Immuno-oncology Therapy Consumption Market Share by Countries in 2017
Table Europe Immuno-oncology Therapy Value by Countries (2013-2018) ($ Millions)
Table Europe Immuno-oncology Therapy Value Market Share by Countries (2013-2018)
Figure Europe Immuno-oncology Therapy Value Market Share by Countries in 2017
Table Europe Immuno-oncology Therapy Consumption by Type (2013-2018) (K Units)
Table Europe Immuno-oncology Therapy Consumption Market Share by Type (2013-2018)
Figure Europe Immuno-oncology Therapy Consumption Market Share by Type in 2017
Table Europe Immuno-oncology Therapy Consumption by Application (2013-2018) (K Units)
Table Europe Immuno-oncology Therapy Consumption Market Share by Application (2013-2018)
Figure Europe Immuno-oncology Therapy Consumption Market Share by Application in 2017
Figure Germany Immuno-oncology Therapy Consumption Growth 2013-2018 (K Units)
Figure Germany Immuno-oncology Therapy Value Growth 2013-2018 ($ Millions)
Figure France Immuno-oncology Therapy Consumption Growth 2013-2018 (K Units)
Figure France Immuno-oncology Therapy Value Growth 2013-2018 ($ Millions)
Figure UK Immuno-oncology Therapy Consumption Growth 2013-2018 (K Units)
Figure UK Immuno-oncology Therapy Value Growth 2013-2018 ($ Millions)
Figure Italy Immuno-oncology Therapy Consumption Growth 2013-2018 (K Units)
Figure Italy Immuno-oncology Therapy Value Growth 2013-2018 ($ Millions)
Figure Russia Immuno-oncology Therapy Consumption Growth 2013-2018 (K Units)
Figure Russia Immuno-oncology Therapy Value Growth 2013-2018 ($ Millions)
Figure Spain Immuno-oncology Therapy Consumption Growth 2013-2018 (K Units)
Figure Spain Immuno-oncology Therapy Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Immuno-oncology Therapy Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa Immuno-oncology Therapy Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Immuno-oncology Therapy Consumption Market Share by Countries in 2017
Table Middle East & Africa Immuno-oncology Therapy Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Immuno-oncology Therapy Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Immuno-oncology Therapy Value Market Share by Countries in 2017
Table Middle East & Africa Immuno-oncology Therapy Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa Immuno-oncology Therapy Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Immuno-oncology Therapy Consumption Market Share by Type in 2017
Table Middle East & Africa Immuno-oncology Therapy Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa Immuno-oncology Therapy Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Immuno-oncology Therapy Consumption Market Share by Application in 2017
Figure Egypt Immuno-oncology Therapy Consumption Growth 2013-2018 (K Units)
Figure Egypt Immuno-oncology Therapy Value Growth 2013-2018 ($ Millions)
Figure South Africa Immuno-oncology Therapy Consumption Growth 2013-2018 (K Units)
Figure South Africa Immuno-oncology Therapy Value Growth 2013-2018 ($ Millions)
Figure Israel Immuno-oncology Therapy Consumption Growth 2013-2018 (K Units)
Figure Israel Immuno-oncology Therapy Value Growth 2013-2018 ($ Millions)
Figure Turkey Immuno-oncology Therapy Consumption Growth 2013-2018 (K Units)
Figure Turkey Immuno-oncology Therapy Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Immuno-oncology Therapy Consumption Growth 2013-2018 (K Units)
Figure GCC Countries Immuno-oncology Therapy Value Growth 2013-2018 ($ Millions)
Table Immuno-oncology Therapy Distributors List
Table Immuno-oncology Therapy Customer List
Figure Global Immuno-oncology Therapy Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global Immuno-oncology Therapy Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Immuno-oncology Therapy Consumption Forecast by Countries (2018-2023) (K Units)
Table Global Immuno-oncology Therapy Consumption Market Forecast by Regions
Table Global Immuno-oncology Therapy Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Immuno-oncology Therapy Value Market Share Forecast by Regions
Figure Americas Immuno-oncology Therapy Consumption 2018-2023 (K Units)
Figure Americas Immuno-oncology Therapy Value 2018-2023 ($ Millions)
Figure APAC Immuno-oncology Therapy Consumption 2018-2023 (K Units)
Figure APAC Immuno-oncology Therapy Value 2018-2023 ($ Millions)
Figure Europe Immuno-oncology Therapy Consumption 2018-2023 (K Units)
Figure Europe Immuno-oncology Therapy Value 2018-2023 ($ Millions)
Figure Middle East & Africa Immuno-oncology Therapy Consumption 2018-2023 (K Units)
Figure Middle East & Africa Immuno-oncology Therapy Value 2018-2023 ($ Millions)
Figure United States Immuno-oncology Therapy Consumption 2018-2023 (K Units)
Figure United States Immuno-oncology Therapy Value 2018-2023 ($ Millions)
Figure Canada Immuno-oncology Therapy Consumption 2018-2023 (K Units)
Figure Canada Immuno-oncology Therapy Value 2018-2023 ($ Millions)
Figure Mexico Immuno-oncology Therapy Consumption 2018-2023 (K Units)
Figure Mexico Immuno-oncology Therapy Value 2018-2023 ($ Millions)
Figure Brazil Immuno-oncology Therapy Consumption 2018-2023 (K Units)
Figure Brazil Immuno-oncology Therapy Value 2018-2023 ($ Millions)
Figure China Immuno-oncology Therapy Consumption 2018-2023 (K Units)
Figure China Immuno-oncology Therapy Value 2018-2023 ($ Millions)
Figure Japan Immuno-oncology Therapy Consumption 2018-2023 (K Units)
Figure Japan Immuno-oncology Therapy Value 2018-2023 ($ Millions)
Figure Korea Immuno-oncology Therapy Consumption 2018-2023 (K Units)
Figure Korea Immuno-oncology Therapy Value 2018-2023 ($ Millions)
Figure Southeast Asia Immuno-oncology Therapy Consumption 2018-2023 (K Units)
Figure Southeast Asia Immuno-oncology Therapy Value 2018-2023 ($ Millions)
Figure India Immuno-oncology Therapy Consumption 2018-2023 (K Units)
Figure India Immuno-oncology Therapy Value 2018-2023 ($ Millions)
Figure Australia Immuno-oncology Therapy Consumption 2018-2023 (K Units)
Figure Australia Immuno-oncology Therapy Value 2018-2023 ($ Millions)
Figure Germany Immuno-oncology Therapy Consumption 2018-2023 (K Units)
Figure Germany Immuno-oncology Therapy Value 2018-2023 ($ Millions)
Figure France Immuno-oncology Therapy Consumption 2018-2023 (K Units)
Figure France Immuno-oncology Therapy Value 2018-2023 ($ Millions)
Figure UK Immuno-oncology Therapy Consumption 2018-2023 (K Units)
Figure UK Immuno-oncology Therapy Value 2018-2023 ($ Millions)
Figure Italy Immuno-oncology Therapy Consumption 2018-2023 (K Units)
Figure Italy Immuno-oncology Therapy Value 2018-2023 ($ Millions)
Figure Russia Immuno-oncology Therapy Consumption 2018-2023 (K Units)
Figure Russia Immuno-oncology Therapy Value 2018-2023 ($ Millions)
Figure Spain Immuno-oncology Therapy Consumption 2018-2023 (K Units)
Figure Spain Immuno-oncology Therapy Value 2018-2023 ($ Millions)
Figure Egypt Immuno-oncology Therapy Consumption 2018-2023 (K Units)
Figure Egypt Immuno-oncology Therapy Value 2018-2023 ($ Millions)
Figure South Africa Immuno-oncology Therapy Consumption 2018-2023 (K Units)
Figure South Africa Immuno-oncology Therapy Value 2018-2023 ($ Millions)
Figure Israel Immuno-oncology Therapy Consumption 2018-2023 (K Units)
Figure Israel Immuno-oncology Therapy Value 2018-2023 ($ Millions)
Figure Turkey Immuno-oncology Therapy Consumption 2018-2023 (K Units)
Figure Turkey Immuno-oncology Therapy Value 2018-2023 ($ Millions)
Figure GCC Countries Immuno-oncology Therapy Consumption 2018-2023 (K Units)
Figure GCC Countries Immuno-oncology Therapy Value 2018-2023 ($ Millions)
Table Global Immuno-oncology Therapy Consumption Forecast by Type (2018-2023) (K Units)
Table Global Immuno-oncology Therapy Consumption Market Share Forecast by Type (2018-2023)
Table Global Immuno-oncology Therapy Value Forecast by Type (2018-2023) ($ Millions)
Table Global Immuno-oncology Therapy Value Market Share Forecast by Type (2018-2023)
Table Global Immuno-oncology Therapy Consumption Forecast by Application (2018-2023) (K Units)
Table Global Immuno-oncology Therapy Consumption Market Share Forecast by Application (2018-2023)
Table Global Immuno-oncology Therapy Value Forecast by Application (2018-2023) ($ Millions)
Table Global Immuno-oncology Therapy Value Market Share Forecast by Application (2018-2023)
Table Amgen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Amgen Immuno-oncology Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Amgen Immuno-oncology Therapy Market Share (2016-2018)
Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AstraZeneca Immuno-oncology Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
Figure AstraZeneca Immuno-oncology Therapy Market Share (2016-2018)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bristol-Myers Squibb Immuno-oncology Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Bristol-Myers Squibb Immuno-oncology Therapy Market Share (2016-2018)
Table Eli-Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli-Lilly Immuno-oncology Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Eli-Lilly Immuno-oncology Therapy Market Share (2016-2018)
Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Immuno-oncology Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Roche Immuno-oncology Therapy Market Share (2016-2018)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Immuno-oncology Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
Figure GlaxoSmithKline Immuno-oncology Therapy Market Share (2016-2018)
Table Janssen Biotech Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Janssen Biotech Immuno-oncology Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Janssen Biotech Immuno-oncology Therapy Market Share (2016-2018)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Immuno-oncology Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Merck Immuno-oncology Therapy Market Share (2016-2018)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Immuno-oncology Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Novartis Immuno-oncology Therapy Market Share (2016-2018)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Immuno-oncology Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Pfizer Immuno-oncology Therapy Market Share (2016-2018)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Spectrum Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Takeda Basic Information, Manufacturing Base, Sales Area and Its Competitors